CJC-1295 and ipamorelin are investigational peptide compounds that have been studied for their effects on growth-hormone signaling. CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog, while ipamorelin is a growth-hormone secretagogue. These compounds are sometimes discussed in the context of body composition, recovery, and wellness, but evidence for many marketed uses remains limited.
Because these are not FDA-approved treatments for general anti-aging, weight loss, muscle building, or wellness, any use should be evaluated by a qualified healthcare professional. The exact formulation, concentration, route, and dosing schedule should be verified by the dispensing pharmacy and prescribing clinician.
CJC-1295 and ipamorelin are investigational peptide compounds that have been studied for their effects on growth-hormone signaling. CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog, while ipamorelin is a growth-hormone secretagogue. These compounds are sometimes discussed in the context of body composition, recovery, and wellness, but evidence for many marketed uses remains limited.
Because these are not FDA-approved treatments for general anti-aging, weight loss, muscle building, or wellness, any use should be evaluated by a qualified healthcare professional. The exact formulation, concentration, route, and dosing schedule should be verified by the dispensing pharmacy and prescribing clinician.
